Ribotin-e Tablet
NDC Package 59088-182-58
Package Information
Ribotin-e (ferrous fumarate, folic acid) tablets is ribotin-E TM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. This formulation utilizes a tablet delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-182.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 45 mg/1
- ASCORBIC ACID 250 mg/1
- BIOTIN 100 ug/1
- BORON 25 ug/1
- CALCIUM CARBONATE 75 mg/1
- CHOLECALCIFEROL 13.75 ug/1
- CHROMIUM NICOTINATE 37.5 ug/1
- CUPROUS OXIDE 1 mg/1
- CYANOCOBALAMIN 13 ug/1
- FERROUS FUMARATE 9 mg/1
- FOLIC ACID 500 ug/1
- MAGNESIUM OXIDE 37.5 mg/1
- MANGANESE SULFATE .75 mg/1
- MOLYBDENUM 25 ug/1
- NIACINAMIDE 22.5 mg/1
- PANTOTHENIC ACID 15 mg/1
- POTASSIUM CHLORIDE 24.5 mg/1
- POTASSIUM IODIDE 25 ug/1
- PYRIDOXINE HYDROCHLORIDE 6 mg/1
- RIBOFLAVIN 3.35 mg/1
- SELENIUM 30 ug/1
- THIAMINE MONONITRATE 3.25 mg/1
- VITAMIN A ACETATE 1500 ug/1
- ZINC OXIDE 15 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Nicotinic Acid - [EPC] (Established Pharmacologic Class)
- Nicotinic Acids - [CS]
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 59088 - Puretek Corporation
- 59088-182 - Ribotin-e
- 59088-182-58 - 60 TABLET in 1 BOTTLE, PLASTIC
- 59088-182 - Ribotin-e
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59088-182-58 identifies a specific commercial package of 60 tablet in 1 bottle, plastic of Ribotin-e, a human prescription drug labeled by Puretek Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This tablet is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; biotin; boron; calcium carbonate; cholecalciferol; chromium nicotinate; cuprous oxide; cyanocobalamin; ferrous fumarate; folic acid; magnesium oxide; manganese sulfate; molybdenum; niacinamide; pantothenic acid; potassium chloride; potassium iodide; pyridoxine hydrochloride; riboflavin; selenium; thiamine mononitrate; vitamin a acetate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on February 11, 2021. The current certification is valid through December 31, 2026.
How is this Puretek Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088018258. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.